Startups
MARS portable CT imaging systems bring diagnostics closer to patients with unprecedented spectral resolution and extremely low radiation doses.
Overview
Location
New Zealand
Total raised
$15M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 14, 2026 | MARS Bioimaging Secures $15M to Scale World’s First Portable Spectral CT Scanners | MARS Bioimaging’s Group CEO Dr Ojas Mahapatra (left) with Chairman Chris Stoelhorst What You Should Know – MARS Bioimaging, a New Zealand–headquartered pioneer in medical imaging, secures $15M in Series A funding round. Led by Pacific Chann... |
| Sep 14, 2024 | Современные детекторы рентгеновского излучения | Введение Рентгеновский снимок руки Альберта фон Кёлликера, сделанный Вильгельмом Рентгеном 23 января 1896 года. Источник Вильгельм Рентген открыл рентгеновское излучение 8 ноября 1895 года, когда проводил эксперименты с катодными лучами в в... |
| Mars Bioimaging | “MARS Bioimaging” |
Reviews 0
FAQ about MARS Bioimaging
How much funding has MARS Bioimaging raised?
MARS Bioimaging has raised $15M in total across 1 funding round.
What has the press written about MARS Bioimaging?
Parsers VC has collected 4 articles mentioning MARS Bioimaging, among them “MARS Bioimaging Secures $15M to Scale World’s First Portable Spectral CT Scanners” (Jan 14, 2026) and “Современные детекторы рентгеновского излучения” (Sep 14, 2024).
Is MARS Bioimaging still active?
Yes, MARS Bioimaging is active; its latest activity on Parsers VC dates from Jan 15, 2026.